 Y-mAbs Therapeutics, Inc. NASDAQ:YMAB Q3 2022 Earnings Conference Call November 8, 2022 4:00 PM ET Company Participants Thomas Gad - Founder, Interim CEO President Sue Smith - SVP Chief Commercial Officer Bo Kruse - EVP, Secretary, Treasurer CFO Conference Call Participants Alec Stranahan - Bank of America Merrill Lynch Etzer Darout - BMO Capital Markets William Maughan - Canaccord Genuity Edouard Mullarky - Guggenheim Securities Tessa Romero - JPMorgan Chase Co. Sebastiaan van der Schoot - Kempen Co. Joseph Thome - Cowen Operator Good afternoon, and welcome to the Y-mAbs Therapeutics, Inc. Earnings Conference Call for the Third Quarter of 2022. Operator Instructions. 